Routine

Allergic rhinitis (hay fever, allergic rhinoconjunctivitis)

Aeroallergen allergy · ENT
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

IgE-mediated nasal mucosal inflammation to aeroallergens — sneezing, nasal itch, rhinorrhoea and congestion, often with allergic conjunctivitis. Common and non-emergent; the ED role is symptom relief, distinguishing it from infection, and recognising associated asthma. NOTE: no dedicated source PDF was supplied for this topic — content synthesised from standard ED practice plus the pregnancy and cat-allergy sources provided; clinician to verify against a primary allergic-rhinitis reference. DRAFT for clinician review.

Red flags

  • Unilateral symptoms with bloody or purulent discharge (foreign body, tumour, invasive sinusitis)
  • Clear unilateral rhinorrhoea after head trauma (CSF leak)
  • Orbital/facial swelling or vision change (complicated sinusitis)
  • High fever or systemic illness

Assessment

Differential diagnosis

  • Viral URTI / rhinosinusitis
  • Non-allergic (vasomotor) rhinitis
  • Rhinitis medicamentosa (decongestant overuse)
  • Acute bacterial rhinosinusitis
  • Nasal foreign body (children)
  • CSF rhinorrhoea (unilateral clear discharge after trauma)

Investigations

  • Clinical
  • Allergist skin-prick / specific-IgE for culprit identification or immunotherapy
  • No ED test required

Management

  • Allergen avoidance + saline nasal irrigation
  • Intranasal corticosteroid (most effective, especially for congestion)
  • Add / alternatively use a second-generation oral or intranasal antihistamine
  • Antihistamine eye drops for ocular symptoms
  • Leukotriene antagonist as an alternative
  • Intranasal decongestant short-term only
  • Assess for and treat coexisting asthma
  • Refer to allergist for poorly controlled disease or immunotherapy

Drugs & doses

Saline nasal spray / irrigation — nonpharmacologic first step.
Intranasal corticosteroid (e.g. fluticasone, mometasone, budesonide) — most effective single agent; best used regularly, onset over days. [Exact mg doses not drawn from a dedicated source.]
Second-generation oral H1 antihistamine (loratadine, cetirizine, fexofenadine, levocetirizine) — for sneeze/itch/rhinorrhoea.
Intranasal antihistamine (azelastine, olopatadine) — alternative or add-on.
Antihistamine–mast-cell-stabiliser eye drops for ocular symptoms (see allergic conjunctivitis).
Leukotriene receptor antagonist (montelukast) — alternative; less effective than intranasal steroid and carries a boxed warning for neuropsychiatric effects.
Intranasal decongestant (oxymetazoline) — short-term only (≤3 days) to avoid rhinitis medicamentosa; oral pseudoephedrine as needed (caution/avoid in hypertension).

Disposition

Outpatient / GP management; allergist referral for refractory disease or immunotherapy.

Complications & pitfalls

  • Impaired sleep / quality of life
  • Sinusitis
  • Exacerbation of coexisting asthma
  • Rhinitis medicamentosa from decongestant overuse

Exam pearls

  • Intranasal corticosteroid is the most effective monotherapy and beats oral antihistamine for congestion
  • Limit topical decongestants to ≤3 days
  • Itchy/watery/sneezy with clear rhinorrhoea favours allergic over infective rhinitis
  • Always ask about and manage comorbid asthma
  • For pregnancy dosing see the 'Allergic disease in pregnancy' entry

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.